# A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

> **NCT07263178** · — · RECRUITING · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 1000 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Second and later-line palliative chemotherapy

## Key facts

- **NCT ID:** NCT07263178
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263178, "A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07263178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*